Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Other Non Operating Income (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Other Non Operating Income for 17 consecutive years, with $400000.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income rose 33.33% to $400000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $800000.0 through Dec 2025, down 27.27% year-over-year, with the annual reading at $800000.0 for FY2025, 27.27% down from the prior year.
  • Other Non Operating Income for Q4 2025 was $400000.0 at Myriad Genetics, roughly flat from $400000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $120.6 million in Q3 2021, with the low at -$2.4 million in Q2 2023.
  • Average Other Non Operating Income over 5 years is $8.1 million, with a median of $100000.0 recorded in 2022.
  • The sharpest move saw Other Non Operating Income surged 7637.5% in 2021, then tumbled 2500.0% in 2023.
  • Over 5 years, Other Non Operating Income stood at $120.6 million in 2021, then plummeted by 99.59% to $500000.0 in 2022, then crashed by 240.0% to -$700000.0 in 2023, then soared by 142.86% to $300000.0 in 2024, then surged by 33.33% to $400000.0 in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at $400000.0, $400000.0, and -$100000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.